Merck & Co., Inc. — Director's Dealing 2020

May 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-05-01

Reporting Person: DeLuca Richard R. (EVP&Pres, Merck Animal Heallth)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-01	Stock Option (Right to Buy)	$77.67	A	75514	Acquired	2030-04-30	Common Stock (75514)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	87525.616	Direct
Common Stock - 401(k) Plan	1103.701	Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through April 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.